Pharmaceuticals News
Feature article - The great pharma supply chain realignment
Andrew Warmington
Halozyme abandons Evotec bid
Andrew Warmington
Siegfried opens drug substances R&D centre
Andrew Warmington
Three invest further into ADCs
Andrew Warmington
Cambrex exits drug product
Andrew Warmington
Siegfried breaks ground on R&D centre
Andrew Warmington
Drug product centre opens
Andrew Warmington
Evonik realigns Health Care
Andrew Warmington
Quotient integrates drug substance into platform
Andrew Warmington
CordenPharma buys Vifor sites
Andrew Warmington
New owner for Envigo
Andrew Warmington
Quotient to expand Alnwick
Andrew Warmington